Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

GMP in Latin America (ANVISA, COFEPRIS)

How ANVISA GMP Ensures Quality Control for Pharmaceuticals in Brazil

Posted on December 27, 2024 By digi

How ANVISA GMP Ensures Quality Control for Pharmaceuticals in Brazil How ANVISA GMP Ensures Quality Control for Pharmaceuticals in Brazil Introduction to ANVISA and the Role of GMP in Quality Control The National Health Surveillance Agency (ANVISA) is the regulatory authority in Brazil that is responsible for overseeing the safety, efficacy, and quality of pharmaceutical…

Read More “How ANVISA GMP Ensures Quality Control for Pharmaceuticals in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

How to Address Non-Conformities Identified by COFEPRIS During GMP Inspections

Posted on December 26, 2024 By digi

How to Address Non-Conformities Identified by COFEPRIS During GMP Inspections How to Address Non-Conformities Identified by COFEPRIS During GMP Inspections Introduction to COFEPRIS and GMP Inspections The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is Mexico’s regulatory authority responsible for overseeing the safety, efficacy, and quality of pharmaceutical products. One of COFEPRIS’s most…

Read More “How to Address Non-Conformities Identified by COFEPRIS During GMP Inspections” »

GMP in Latin America (ANVISA, COFEPRIS)

The Future of ANVISA GMP Regulations in Brazil’s Pharmaceutical Industry

Posted on December 26, 2024 By digi

The Future of ANVISA GMP Regulations in Brazil’s Pharmaceutical Industry The Future of ANVISA GMP Regulations in Brazil’s Pharmaceutical Industry Introduction to ANVISA GMP and Its Role in Brazil’s Pharmaceutical Industry The National Health Surveillance Agency (ANVISA) is the regulatory authority responsible for overseeing the safety, efficacy, and quality of pharmaceutical products in Brazil. Through…

Read More “The Future of ANVISA GMP Regulations in Brazil’s Pharmaceutical Industry” »

GMP in Latin America (ANVISA, COFEPRIS)

Best Practices for Ensuring COFEPRIS GMP Compliance in Mexican Pharmaceutical Operations

Posted on December 25, 2024 By digi

Best Practices for Ensuring COFEPRIS GMP Compliance in Mexican Pharmaceutical Operations Best Practices for Ensuring COFEPRIS GMP Compliance in Mexican Pharmaceutical Operations Introduction to COFEPRIS GMP Compliance The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is the regulatory body responsible for ensuring the safety, quality, and efficacy of pharmaceutical products in Mexico. COFEPRIS…

Read More “Best Practices for Ensuring COFEPRIS GMP Compliance in Mexican Pharmaceutical Operations” »

GMP in Latin America (ANVISA, COFEPRIS)

How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil

Posted on December 25, 2024 By digi

How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil Introduction to ANVISA GMP and Pharmaceutical Contamination The National Health Surveillance Agency (ANVISA) is Brazil’s regulatory authority responsible for overseeing the safety, efficacy, and quality of pharmaceutical products. One of the primary ways ANVISA ensures drug safety…

Read More “How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

The Role of Documentation in Achieving ANVISA GMP Compliance

Posted on December 24, 2024 By digi

The Role of Documentation in Achieving ANVISA GMP Compliance The Role of Documentation in Achieving ANVISA GMP Compliance Introduction to ANVISA GMP and the Importance of Documentation The National Health Surveillance Agency (ANVISA) plays a critical role in ensuring the safety, quality, and efficacy of pharmaceutical products in Brazil. One of the primary regulatory frameworks…

Read More “The Role of Documentation in Achieving ANVISA GMP Compliance” »

GMP in Latin America (ANVISA, COFEPRIS)

How to Align ANVISA GMP with Other Latin American and Global GMP Standards

Posted on December 23, 2024 By digi

How to Align ANVISA GMP with Other Latin American and Global GMP Standards How to Align ANVISA GMP with Other Latin American and Global GMP Standards Introduction to GMP Harmonization Good Manufacturing Practices (GMP) are essential for ensuring that pharmaceutical products are produced consistently and safely. In many countries, regulatory bodies like ANVISA (Brazil’s National…

Read More “How to Align ANVISA GMP with Other Latin American and Global GMP Standards” »

GMP in Latin America (ANVISA, COFEPRIS)

COFEPRIS GMP Compliance for Small Pharma Companies in Mexico

Posted on December 23, 2024 By digi

COFEPRIS GMP Compliance for Small Pharma Companies in Mexico COFEPRIS GMP Compliance for Small Pharma Companies in Mexico Introduction to COFEPRIS and GMP Compliance for Small Pharma Companies The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is the regulatory body in Mexico that oversees the safety, efficacy, and quality of pharmaceutical products. To…

Read More “COFEPRIS GMP Compliance for Small Pharma Companies in Mexico” »

GMP in Latin America (ANVISA, COFEPRIS)

How ANVISA GMP Guidelines Promote Drug Quality in Brazil

Posted on December 22, 2024 By digi

How ANVISA GMP Guidelines Promote Drug Quality in Brazil How ANVISA GMP Guidelines Promote Drug Quality in Brazil Introduction to ANVISA and the Importance of GMP Guidelines The National Health Surveillance Agency (ANVISA) is the Brazilian regulatory body that ensures the safety, efficacy, and quality of pharmaceuticals in Brazil. As part of its mission to…

Read More “How ANVISA GMP Guidelines Promote Drug Quality in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

How COFEPRIS GMP Supports Drug Safety in Mexico

Posted on December 22, 2024 By digi

How COFEPRIS GMP Supports Drug Safety in Mexico How COFEPRIS GMP Supports Drug Safety in Mexico Introduction to COFEPRIS and Drug Safety In Mexico, the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is responsible for ensuring the safety, quality, and efficacy of pharmaceutical products. One of the main regulatory frameworks that COFEPRIS enforces…

Read More “How COFEPRIS GMP Supports Drug Safety in Mexico” »

GMP in Latin America (ANVISA, COFEPRIS)

Posts pagination

Previous 1 2 3 … 5 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Qualify HVAC Systems in Warehouses to Maintain GMP Storage Conditions

    Qualify HVAC Systems in Warehouses… Read more

GMP in Latin America (ANVISA, COFEPRIS)

  • The Importance of ANVISA GMP Compliance for Pharmaceutical Manufacturers in Latin America
  • How to Integrate ANVISA and COFEPRIS GMP Guidelines into Your Pharmaceutical QMS
  • The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance
  • How ANVISA GMP Regulations Influence the Production of Vaccines
  • How COFEPRIS GMP Ensures the Quality of Biological Drugs
  • How to Achieve GMP Compliance for Pharmaceutical Packaging in Brazil
  • How ANVISA GMP Guidelines Support Sustainable Manufacturing Practices in Brazil
  • How COFEPRIS GMP Supports the Manufacturing of Orphan Drugs
  • How ANVISA GMP Guidelines Ensure Compliance for Pharmaceutical Exports
  • COFEPRIS GMP and the Role of Biopharmaceutical Manufacturing in Mexico

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme